Nuvisertib: Regulatory submission for myelofibrosis in FY 2027 (Sumitomo Dainippon) - May 14, 2025 - FY2024 Results: Launch in US/Japan for myelofibrosis in FY 2028
Filing • Launch Japan • Launch US • Hematological Malignancies • Myelofibrosis • Myeloproliferative Neoplasm • Oncology
|